You are here: Industry Insights > Antibiotics

News List

Medicines Discovery Catapult, ANTRUK start antibiotics project pharmatimes
October 23, 2017
A new research project has begun at Warwick University striving to tackle antimicrobial resistance, one of the fastest growing health problems around the globe.
Mutabilis joins European ENABLE project to develop new antibiotics pharmaceufical-technology
October 19, 2017
ENABLE managing entity leader Anders Karlén said: “We welcome the Mutabilis programme into the IMI ENABLE project.
Warp Drive and Roche collaborate to develop new classes of antibiotics pharmaceufical-technology
October 18, 2017
US-based firm Warp Drive Bio has formed a strategic alliance with Roche for the discovery and development of several new classes of antibiotics.
WHO: Antibiotics in an Emergency! A Review of Current R&D Situation of Global Antibiotics (2) en-cphi.cn
October 17, 2017
The following chart shows the quantity of antibacterial compounds in Phase 1-3 clinical development, and they are the future “ammunition” for mankind.
WHO: Antibiotics in an Emergency! A Review of Current R&D Situation of Global Antibiotics (1) en-cphi.cn
October 16, 2017
A report by the World Health Organization (WHO) recently shows a serious lack of new antibiotics under development to combat the growing threat of antimicrobial resistance.
The world is running out of antibiotics: WHO confirms biospectrumasia
September 21, 2017
Most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions
Superbug squashed by super-team of antibiotics europeanpharmaceuticalreview
August 23, 2017
Researchers have found that a novel combination of antibiotics that was able to kill E. coli carrying mcr-1 and ndm-5 genes within 24 hours…
Years after the Restriction Order of Antibiotics Usage, the Antibiotic Market Reshuffled to Enter th en-cphi.cn
July 28, 2017
Under the restriction order of antibiotics usage, many antibiotics have been listed in the scope of “restricted drugs” and “special drugs”, and the market development has been subject to large restrictions, with sales shrinking and market reshuffled.
Market pressures and inadequate production restrict access to antibiotics europeanpharmaceuticalreview
May 16, 2017
Antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market.
Fungi have enormous potential for new antibiotics worldpharmanews
April 21, 2017
Fungi are a potential goldmine for the production of pharmaceuticals.

Previous page 1 2 3 4 5 6 7 8 Next page